NCT06007092 - Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions

Head and Neck CarcinomaAdult Disease

Interventions

BIOLOGICAL

HPVDC injection level dose 1

patient receive 3 injections of vaccine at the same level dose

BIOLOGICAL

placebo injection level dose 1

patient receive 3 injections of vaccine at the same level dose

BIOLOGICAL

HPVDC injection level dose 2

patient receive 3 injections of vaccine at the same level dose

BIOLOGICAL

placebo injection level dose 2

patient receive 3 injections of vaccine at the same level dose

Trial Locations (1)

RECRUITING

Gustave Roussy, Villejuif